Quick answer
Stem cell therapy for Rheumatoid Arthritis aims to balance the immune system using Mesenchymal Stem Cells' properties to suppress inflammation and repair cartilage. This approach, powered by EHL BIO's technology, focuses on enhancing long-term quality of life as evaluated by the EHL team.
Key takeaways
- Stem cells possess immune-modulating properties that help balance the immune system in Rheumatoid Arthritis.
- EHL BIO's technology yields high cell counts under GMP Class 100 standards.
- RASTEM Inj. is currently in the medical development phase as a dedicated solution for Rheumatoid Arthritis.
- Using autologous cells minimizes the risk of immune rejection and ensures high safety levels.
Understanding Rheumatoid Arthritis and the Immune System
Rheumatoid Arthritis is an autoimmune disorder affecting joint tissues, primarily caused by an imbalance between Th1 and Th2 T-cells. The core of managing this condition lies in rebalancing the immune system. Modern regenerative medicine focuses on this aspect for the goal of recovery and improved quality of life.
Mechanism of Stem Cells in Joint Regeneration
Mesenchymal Stem Cells (MSCs) possess a 'Homing Effect,' migrating directly to sites of inflammation to suppress inflammatory processes and stimulate tissue regeneration. EHL BIO’s research focuses on autologous adipose-derived stem cells, which offer high safety and effectively minimize immune rejection risks.
Our goal is to support inflammatory recovery through stem cell innovation, restoring quality of life for our clients.
RASTEM Innovation and GMP Standards
EHL BIO has developed RASTEM Inj., a stem cell innovation specifically designed for Rheumatoid Arthritis. Under the leadership of expert researchers, we utilize patented technology to isolate high-purity cells. The entire production process occurs within GMP facilities certified in South Korea, utilizing Class 100 clean rooms to ensure the highest quality and safety.
Service Process and Collaboration Network
Receiving services at EHL Cell Clinic in Seoul, South Korea, begins with a consultation via EHL Thailand's Thai-speaking team. A single fat tissue collection is performed, which can be cultured and utilized for multiple sessions through advanced freezing technology. EHL BIO maintains a network of over 100 partner hospitals in Korea to ensure patients receive cutting-edge care with continuous follow-up even after returning to Thailand.
Frequently asked questions
Is stem cell therapy for Rheumatoid Arthritis safe?
It is highly safe as EHL BIO uses autologous cells, minimizing immune rejection risks, and all processes are conducted in GMP Class 100 laboratories.
What are the long-term recovery goals?
The goal is to balance the immune system, reduce inflammation, and improve quality of life in movement. Results depend on the evaluation of the EHL team and individual biological responses.
How does RASTEM differ from conventional methods?
RASTEM focuses on recovery goals and immune rebalancing at the source using high-purity cells to promote better quality of life as evaluated by the EHL team.
Related conditions
Based on EHL BIO information: EHL BIO · EHL BIO · EHL BIO · EHL BIO. Each care plan follows an individual EHL assessment.
